SCHEMBL688331

SCHEMBL688331

CCOc1cccc([C@H](CC(=O)O)NC(=O)Nc2c(O)c(CC)cn(Cc3c(Cl)cccc3OCC)c2=O)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.38
FFAR1 O14842 2/20 0.36
ALDH1A1 P00352 3/20 0.35
KDM4E B2RXH2 2/20 0.35
PTGER3 P43115 2/20 0.34
KMT2A Q03164 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33
CYP2C9 P11712 2/20 0.33
CYP2C19 P33261 2/20 0.33
CYP1A2 P05177 1/20 0.33
CTSA P10619 1/20 0.33
POLB P06746 1/20 0.33
KCNB1 Q14721 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP26A1 O43174 1/20 0.32
CASP1 P29466 2/20 0.32
CASP3 P42574 2/20 0.32
CASP7 P55210 2/20 0.32
CASP8 Q14790 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL687724 0.95 SMN1; SMN2 (0.36) SMN1; SMN2FFAR1ALDH1A1KDM4EPTGER3
SCHEMBL687970 0.94 SMN1; SMN2 (0.41) SMN1; SMN2FFAR1ALDH1A1KDM4EPTGER3
SCHEMBL27741947 0.94 SMN1; SMN2 (0.41) SMN1; SMN2FFAR1ALDH1A1KDM4EPTGER3
SCHEMBL686989 0.93 SMN1; SMN2 (0.38) SMN1; SMN2FFAR1ALDH1A1KDM4EPTGER3
SCHEMBL688582 0.91 SMN1; SMN2 (0.39) SMN1; SMN2FFAR1ALDH1A1KDM4EPTGER3
SCHEMBL688419 0.90 SMN1; SMN2 (0.35) SMN1; SMN2FFAR1ALDH1A1KDM4EPTGER3
SCHEMBL686761 0.89 SMN1; SMN2 (0.37) SMN1; SMN2ALDH1A1KDM4EKMT2ANPSR1
SCHEMBL28780278 0.89 SMN1; SMN2 (0.39) SMN1; SMN2FFAR1ALDH1A1KDM4EPTGER3
SCHEMBL688247 0.89 SMN1; SMN2 (0.39) SMN1; SMN2FFAR1ALDH1A1KDM4EPTGER3
SCHEMBL687688 0.88 SMN1; SMN2 (0.37) SMN1; SMN2FFAR1ALDH1A1KDM4EPTGER3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1203766-B1 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors ENCYSIVE PHARMACEUTICALS INC (US) 2012-02-29 EP disclosed
EP-1203766-A2 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors TEXAS BIOTECHNOLOGY CORPORATION (US) 2002-05-08 EP disclosed